Index AR1 - Anticancer Research

More documents

Recommendations

Info

ANTICANCER RESEARCH International Journal of Cancer Research and Treatment ISSN: 0250-7005 VOLUME 28 2008
Editorial Board ANTICANCER RESEARCH 28: Index (2008) B. B. Aggarwal Cytokine Research Laboratory, Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA J. P. Armand Institut Gustav-Roussy, Villejuif, France D. Assimakopoulos Department of Otorhinolaryngology, Medical School, University of Ioannina, Greece V. I. Avramis Division of Hematology/Oncology, Childrens Hospital, Los Angeles, CA, USA R. C. Bast Department of Translational Research, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA G. Bauer Abteilung Virologie, Institut für Medizinische Mikrobiologie und Hygiene, Universität Freiburg, Germany E. E. Baulieu INSERM U488 and College de France, Le Kremlin-Bicetre, France Y. Becker Department of Molecular Virology, Hebrew University of Jerusalem, Israel E. J. Benz, Jr. Dana-Farber Cancer Institute, Boston, MA, USA J. Bergh Department of Clinical and Molecular Medicine, Radiumhemmet, Karolinska Institute, Stockholm, Sweden J. L. Biedler Department of Biological Sciences, Fordham University, Bronx, NY, USA D. D. Bigner Department of Pathology, Duke University Medical Center, Durham, NC, USA A. Böcking Institute for Cytopathology, University of Düsseldorf, Germany G. Bonadonna Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy F. T. Bosman Institute of Pathology, University of Lausanne, Switzerland G. Broich ASL Lodi, Lodi, Italy J. M. Brown Department of Radiation Oncology, Stanford Medical Center, Stanford, CA, USA Ø. S. Bruland Department of Medical Oncology-Radiotherapy, Norwegian Radium Hospital, Oslo, Norway M. M. Burger Novartis, Basel, Switzerland M. Carbone Cancer Research Center of Hawaii, Honolulu, HI, USA J. Carlsson Department of Biomedical Radiation Sciences, Uppsala University, Sweden A. F. Chambers Department of Oncology, London Regional Cancer Center, London, Ontario, Canada P. Chandra Abt. für Molekularbiologie, Klinikum Wolfgang Goethe-Universität, Frankfurt am Main, Germany L. Cheng Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA J.-G. Chung Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, ROC E. De Clercq Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium W. De Loecker Department of Biochemistry, Katholieke Universiteit Leuven, Belgium W. Den Otter VUMC, Department of Urology, Amsterdam, The Netherlands E. P. Diamandis Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada G. Th. Diamandopoulos Department of Pathology, Harvard Medical School, Boston, MA, USA W. Ebert Thoraxclinic HD-Rohrbach, Heidelberg, Germany U. Eppenberger Laboratory of Biochemistry/Endocrinology, University Clinic, Basel, Switzerland J. A. Fernandez-Pol Metalloproteomics, LLC, Chesterfield, MO, USA I. J. Fidler Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA W. Fiers Department of Molecular Biomedical Research, Ghent University and VIB, Belgium N. E. Fusenig Division of Differentiation, DKFZ, Heidelberg, Germany G. Gabbiani Department of Pathology, University of Geneva, Switzerland A. F. Gazdar Hamon Center for Therapeutic Oncology Research, University of Texas Southeastern Medical Center, Dallas, TX, USA A. Giordano Sbarro Institute for Cancer Research, Temple University, Philadelphia, PA, USA G. Gitsch Department of Gynecology and Obstetrics, University of Freiburg, Germany R. H. Goldfarb Sopherion Therapeutics, Inc., Princeton, NJ, USA J. W. Gorrod Toxicology Unit, John Tabor Laboratories, University of Essex, Colchester, Essex, UK S. Hammarström Department of Immunology, University of Umeä, Sweden I. Hart Centre for Tumour Biology, Institute of Cancer and CR-UK Clinical Centre, Bart’s and The London, Queen Mary’s School of Medicine and Dentistry, London, UK 4173
Page 1: ANTICANCER RESEARCH International J
Page 5 and 6: ANTICANCER RESEARCH 28: Index (2008
Page 7 and 8: Department of Health, Executive Yua
Page 9 and 10: National R&D Program for Cancer Con
Page 11 and 12: Number 1A Experimental Studies ANTI
Page 15 and 16: * ANTICANCER RESEARCH 28: Index (20
Page 17 and 18: Amelanotic Metastasis of Melanoma M
Page 23 and 24: * ANTICANCER RESEARCH 28: Index (20
Page 25 and 26: Detection of Oncogenic DNA Viruses
Page 27 and 28: Gross Thymic Extract, Thymax, Induc
Page 31 and 32: * Number 4A Special Issue on Prosta
Page 37 and 38: Adjuvant Treatment for Elderly Pati
Page 45 and 46: * * ANTICANCER RESEARCH 28: Index (
Page 47 and 48: Number 6B Clinical Studies ANTICANC
Page 49 and 50: Abstracts of the 14th International
Page 51 and 52: Aggrecan, versican, decorin, Wester
Page 53 and 54:
Apoptosis, inotodiol, lanostane tri
Page 55 and 56:
Bone metastases, bisphosphonates, z
Page 57 and 58:
Capecitabine, colorectal cancer, ir
Page 59 and 60:
Chemoresistance, cancer of unknown
Page 61 and 62:
Colorectal adenoma, Cox-2 polymorph
Page 63 and 64:
Cytotoxicity, ferrocene, β-diketon
Page 65 and 66:
Electrochemiluminescence immunoassa
Page 67 and 68:
Ferrocene, β-diketone, cytotoxicit
Page 69 and 70:
Genistein, soy extract, MDA-MB-231
Page 71 and 72:
Histone deacetylase inhibitor, vita
Page 73 and 74:
Infusion, 5-fluorouracil, arterial,
Page 75 and 76:
Liver metastasis, pioglitazone, col
Page 77 and 78:
Melphalan, hyperthermia, apoptosis,
Page 79 and 80:
Mucin, adenocarcinoma, metastatic b
Page 81 and 82:
Oesophageal cancer, carboplatin, el
Page 83 and 84:
P53, syndecan-1, tenascin-C, TATI,
Page 85 and 86:
Plumbagin, apoptosis, pro-apoptotic
Page 87 and 88:
ProGRP, small cell lung cancer, NSE
Page 89 and 90:
RA-resistance, leukemia cells, reti
Page 91 and 92:
S-1, cisplatin, advanced pancreatic
Page 93 and 94:
Sonic hedgehog, breast cancer, estr
Page 95 and 96:
Thrombosis, gynecological cancer, c
Page 97 and 98:
Type of cell death, β-cyclodextrin
Page 99 and 100:
Authors Index (Figures refer to pag
Page 101 and 102:
Cho S-H, 2649 Choi MS, 3777 Chorti
Page 103 and 104:
Giuliani L, 1405 Goda T, 2343 Goess
Page 105 and 106:
Katano M, 731, 2401 Katayama K, 847
Page 107 and 108:
Mahajan A, 741 Maiti A, 3705 Majka
Page 109 and 110:
Onogawa T, 2669 Onouchi S, 145 Onoz
Page 111 and 112:
Scotti M, 1951 Sculli CM, 3055 Seco
Page 113 and 114:
Usami M, 3913 Ushijima R, 601 Usui
Page 115 and 116:
Errata ANTICANCER RESEARCH 28: Inde
Page 117 and 118:
Medicherla et al: TGF-‚ Inhibitor
Page 119 and 120:
Volume 28 (2008), No 2A, page 1072:
Page 121:
Publication Data: ANTICANCER RESEAR
show all

Index AR1 - Anticancer Research

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?